Award
Award #75D30126D21003
Moderna Awarded Multi-Year Contract for Adult COVID-19 Vaccines
Buyer
Centers for Disease Control and Prevention
Award Amount
$29,183,000.00
Ceiling
$29,183,000.00
Awarded
June 01, 2026
Period of Performance
Jun 01, 2026
Identifier
75D30126D21003
NAICS
325412
This IDV contract represents a significant multi-year procurement awarded to Moderna US, Inc., a leading biotechnology company specializing in mRNA-based vaccines. The contract focuses on the supply of adult COVID-19 vaccines for fiscal years 2026 and 2027, underscoring the ongoing public health commitment to managing the pandemic through immunization. The award ensures the availability of a critical healthcare product, supporting the agency’s efforts to protect public health. The scope includes delivery of the designated vaccine formulations as per regulatory and program requirements, facilitating broad immunization accessibility. Awarded on a competitive basis, this contract aligns with federal procurement standards to secure effective pandemic response tools. The agreement commenced in mid-2026 and sets a foundation for continued vaccine distribution and public health preparedness.
Description
FY26-27 ADULT COVID VACCINES EO 14398